The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was  Recruiting
Sponsor:
Collaborator:
University of California, San Francisco
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00451919
First received: March 23, 2007
Last updated: April 3, 2007
Last verified: March 2007

March 23, 2007
April 3, 2007
July 2006
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00451919 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease
Sickle-Cell Disease: Neuroimaging and Cognitive Decline

Sickle cell disease is an inherited blood disorder that affects red blood cells (RBCs). People with sickle cell disease frequently experience anemia, or a low number of RBCs. RBCs are responsible for carrying oxygen to the brain and other body tissues that need oxygen to function properly. The purpose of this study is to determine what changes, which were possibly caused by anemia, exist in the brains of individuals with sickle cell disease.

The role of RBCs is to carry oxygen from the lungs to the brain and other body tissues. Individuals with anemia have unusually low numbers of RBCs. They also often have difficulty concentrating and remembering information, which is likely caused by a reduced oxygen supply to the brain. Previous research has shown that correcting anemia in patients without sickle cell disease improved their memory and attention. The purpose of this study is to examine any abnormal changes in the brains of individuals with sickle cell disease and to determine whether these changes are related to reduced memory and attention capabilities.

Participants will attend one study visit. During this visit, a brain magnetic resonance image (MRI) will be performed while participants complete neuropsychological tests that measure memory, attention, and organizational ability. There will be no follow-up visits.

Observational
Observational Model: Case Control
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Sickle Cell Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
120
Not Provided
Not Provided

Inclusion Criteria:

  • Diagnosis of sickle cell disease

Exclusion Criteria:

  • Pregnancy
  • Claustrophobia
  • Mass lesion (e.g., meningioma, cyst, or spinal block)
  • Need for life support constant monitoring
  • Any unstable condition that is likely to require resuscitation
  • Presence of a pacemaker or other iron-containing magnetic substances in the body
Both
21 Years and older
Yes
Contact: Randall R. Rule, PhD 415-221-4810 ext 4830 randall.rule@ucsf.edu
Contact: Jeffrey Kasten 415-221-4810 ext 2030 jeffrey.kasten@ucsf.edu
United States
 
NCT00451919
375, K01 HL073152
Not Provided
Not Provided
National Heart, Lung, and Blood Institute (NHLBI)
University of California, San Francisco
Principal Investigator: Randall R. Rule, PhD University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
March 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP